Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Daniel M. Togasaki, MD, PhD

    TitleAssociate Professor of Clinical Neurology
    SchoolKeck School of Medicine of USC
    AddressHCT 3000
    Health Sciences Campus
    Los Angeles California 90089
    Phone+1 323 442 5728

       ORNG Applications 

      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Berkovich R, Togasaki DM, Cen SY, Steinman L. CD4 cell response to interval therapy with natalizumab. Ann Clin Transl Neurol. 2015 May; 2(5):570-4..
        View in: PubMed
      2. Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial. JAMA Neurol. 2014 Feb 1; 71(2):141-50..
        View in: PubMed
      3. Factor SA, Wolski K, Togasaki DM, Huyck S, Cantillon M, Ho TW, Hauser RA, Pourcher E. Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease. Mov Disord. 2013 Jun; 28(6):817-20..
        View in: PubMed
      4. Wills AM, Eberly S, Tennis M, Lang AE, Messing S, Togasaki D, Tanner CM, Kamp C, Chen JF, Oakes D, McDermott MP, Schwarzschild MA. Caffeine consumption and risk of dyskinesia in CALM-PD. Mov Disord. 2013 Mar; 28(3):380-3..
        View in: PubMed
      5. Vuckovic MG, Wood RI, Holschneider DP, Abernathy A, Togasaki DM, Smith A, Petzinger GM, Jakowec MW. Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. Neurobiol Dis. 2008 Nov; 32(2):319-27..
        View in: PubMed
      6. Petzinger GM, Walsh JP, Akopian G, Hogg E, Abernathy A, Arevalo P, Turnquist P, Vuckovic M, Fisher BE, Togasaki DM, Jakowec MW. Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. J Neurosci. 2007 May 16; 27(20):5291-300..
        View in: PubMed
      7. Cox H, Togasaki DM, Chen L, Langston JW, Di Monte DA, Quik M. The selective kappa-opioid receptor agonist U50,488 reduces L-dopa-induced dyskinesias but worsens parkinsonism in MPTP-treated primates. Exp Neurol. 2007 May; 205(1):101-7..
        View in: PubMed
      8. Togasaki DM, Hsu A, Samant M, Farzan B, DeLanney LE, Langston JW, Di Monte DA, Quik M. The Webcam system: a simple, automated, computer-based video system for quantitative measurement of movement in nonhuman primates. J Neurosci Methods. 2005 Jun 30; 145(1-2):159-66..
        View in: PubMed
      9. Togasaki DM, Protell P, Tan LC, Langston JW, Di Monte DA, Quik M. Dyskinesias in normal squirrel monkeys induced by nomifensine and levodopa. Neuropharmacology. 2005 Mar; 48(3):398-405..
        View in: PubMed
      10. Hsu A, Togasaki DM, Bezard E, Sokoloff P, Langston JW, Di Monte DA, Quik M. Effect of the D3 dopamine receptor partial agonist BP897 [N-[4-(4-(2-methoxyphenyl)piperazinyl)butyl]-2-naphthamide] on L-3,4-dihydroxyphenylalanine-induced dyskinesias and parkinsonism in squirrel monkeys. J Pharmacol Exp Ther. 2004 Nov; 311(2):770-7..
        View in: PubMed
      11. Tan LC, Protell PH, Langston JW, Togasaki DM. The hyperkinetic abnormal movements scale: a tool for measuring levodopa-induced abnormal movements in squirrel monkeys. Mov Disord. 2002 Sep; 17(5):902-9..
        View in: PubMed
      12. Yee RE, Huang SC, Togasaki DM, Langston JW, Satyamurthy N, Barrio JR. Imaging and therapeutics: the role of neuronal transport in the regional specificity of L-DOPA accumulation in brain. Mol Imaging Biol. 2002 May; 4(3):208-18..
        View in: PubMed
      Daniel's Networks
      Related Concepts
      Derived automatically from this person's publications.
      Co-Authors at USC
      People in Profiles who have published with this person.
      Related Authors at USC
      People who share related concepts with this person.
      Same Department
      Back to TOP